Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor
- PMID: 18708347
- PMCID: PMC2662028
- DOI: 10.1074/jbc.M804114200
Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor
Abstract
The Eph receptor tyrosine kinases regulate a variety of physiological and pathological processes not only during development but also in adult organs, and therefore they represent a promising class of drug targets. The EphA4 receptor plays important roles in the inhibition of the regeneration of injured axons, synaptic plasticity, platelet aggregation, and likely in certain types of cancer. Here we report the first crystal structure of the EphA4 ligand-binding domain, which adopts the same jellyroll beta-sandwich architecture as shown previously for EphB2 and EphB4. The similarity with EphB receptors is high in the core beta-stranded regions, whereas large variations exist in the loops, particularly the D-E and J-K loops, which form the high affinity ephrin binding channel. We also used isothermal titration calorimetry, NMR spectroscopy, and computational docking to characterize the binding to EphA4 of two small molecules, 4- and 5-(2,5 dimethyl-pyrrol-1-yl)-2-hydroxybenzoic acid which antagonize ephrin-induced effects in EphA4-expressing cells. We show that the two molecules bind to the EphA4 ligand-binding domain with K(d) values of 20.4 and 26.4 microm, respectively. NMR heteronuclear single quantum coherence titrations revealed that upon binding, both molecules significantly perturb EphA4 residues Ile(31)-Met(32) in the D-E loop, Gln(43) in the E beta-strand, and Ile(131)-Gly(132) in the J-K loop. Molecular docking shows that they can occupy a cavity in the high affinity ephrin binding channel of EphA4 in a similar manner, by interacting mainly with the EphA4 residues in the E strand and D-E and J-K loops. However, many of the interactions observed in Eph receptor-ephrin complexes are absent, which is consistent with the small size of the two molecules and may account for their relatively weak binding affinity. Thus, our studies provide the first published structure of the ligand-binding domain of an EphA receptor of the A subclass. Furthermore, the results demonstrate that the high affinity ephrin binding channel of the Eph receptors is amenable to targeting with small molecule antagonists and suggest avenues for further optimization.
Figures
Similar articles
-
Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity.J Biol Chem. 2010 Jan 1;285(1):644-54. doi: 10.1074/jbc.M109.064824. Epub 2009 Oct 29. J Biol Chem. 2010. PMID: 19875447 Free PMC article.
-
Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.J Biol Chem. 2008 Oct 24;283(43):29461-72. doi: 10.1074/jbc.M804103200. Epub 2008 Aug 26. J Biol Chem. 2008. PMID: 18728010 Free PMC article.
-
Sizes of interface residues account for cross-class binding affinity patterns in Eph receptor-ephrin families.Proteins. 2014 Mar;82(3):349-53. doi: 10.1002/prot.24414. Epub 2013 Oct 18. Proteins. 2014. PMID: 24105818
-
Roles of Eph receptors and ephrins in segmental patterning.Philos Trans R Soc Lond B Biol Sci. 2000 Jul 29;355(1399):993-1002. doi: 10.1098/rstb.2000.0635. Philos Trans R Soc Lond B Biol Sci. 2000. PMID: 11128993 Free PMC article. Review.
-
Cy5.5-Anti-ephrin receptor B4 (EphB4) humanized monoclonal antibody hAb47.2013 Mar 18 [updated 2013 May 9]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2013 Mar 18 [updated 2013 May 9]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 23678520 Free Books & Documents. Review.
Cited by
-
Structural basis of anti-SARS-CoV-2 activity of HCQ: specific binding to N protein to disrupt its interaction with nucleic acids and LLPS.QRB Discov. 2021 Nov 29;2:e13. doi: 10.1017/qrd.2021.12. eCollection 2021. QRB Discov. 2021. PMID: 37529681 Free PMC article.
-
Structural insights into EphA4 unconventional activation from prediction of the EphA4 and its complex with ribonuclease 1.Am J Cancer Res. 2022 Oct 15;12(10):4865-4878. eCollection 2022. Am J Cancer Res. 2022. PMID: 36381327 Free PMC article.
-
Myricetin Allosterically Inhibits the Dengue NS2B-NS3 Protease by Disrupting the Active and Locking the Inactive Conformations.ACS Omega. 2022 Jan 11;7(3):2798-2808. doi: 10.1021/acsomega.1c05569. eCollection 2022 Jan 25. ACS Omega. 2022. PMID: 35097276 Free PMC article.
-
CTD of SARS-CoV-2 N protein is a cryptic domain for binding ATP and nucleic acid that interplay in modulating phase separation.Protein Sci. 2022 Feb;31(2):345-356. doi: 10.1002/pro.4221. Epub 2021 Nov 22. Protein Sci. 2022. PMID: 34734665 Free PMC article.
-
Curcumin Allosterically Inhibits the Dengue NS2B-NS3 Protease by Disrupting Its Active Conformation.ACS Omega. 2020 Sep 29;5(40):25677-25686. doi: 10.1021/acsomega.0c00039. eCollection 2020 Oct 13. ACS Omega. 2020. PMID: 33073093 Free PMC article.
References
-
- Adams, R. H. (2002) Semin. Cell Dev. Biol. 13 55-60 - PubMed
-
- Pasquale, E. B. (2005) Nat. Rev. Mol. Cell. Biol. 6 462-475 - PubMed
-
- Egea, J., and Klein, R. (2007) Trends Cell Biol. 17 230-238 - PubMed
-
- Luo, L., and Flanagan, J. G. (2007) Neuron 56 284-300 - PubMed
-
- Heroult, M., Schaffner, F., and Augustin, H. G. (2006) Exp. Cell Res. 312 642-650 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous